715-33-3 Usage
General Description
Methyl 3,5-dibromo-2,4-dihydroxy-6-methylbenzoate is a chemical compound with the molecular formula C9H8Br2O4. It is a derivative of benzoic acid and is commonly used in organic synthesis and pharmaceutical research. METHYL 3,5-DIBROMO-2,4-DIHYDROXY-6-METHYLBENZOATE is a white to off-white crystalline solid with a slightly sweet odor. It is insoluble in water but soluble in organic solvents such as ethanol and acetone. Methyl 3,5-dibromo-2,4-dihydroxy-6-methylbenzoate has several potential applications in the pharmaceutical industry, including as an intermediate in the synthesis of various drugs and pharmaceuticals. Additionally, it has been studied for its potential antifungal and antibacterial properties.
Check Digit Verification of cas no
The CAS Registry Mumber 715-33-3 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 7,1 and 5 respectively; the second part has 2 digits, 3 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 715-33:
(5*7)+(4*1)+(3*5)+(2*3)+(1*3)=63
63 % 10 = 3
So 715-33-3 is a valid CAS Registry Number.
InChI:InChI=1/C9H8Br2O4/c1-3-4(9(14)15-2)7(12)6(11)8(13)5(3)10/h12-13H,1-2H3
715-33-3Relevant articles and documents
CANNABIDIOL-TYPE CANNABINOID COMPOUND
-
Paragraph 0037; 0039, (2021/05/29)
The present invention relates to a cannabidiol (CBD) type cannabinoid compound for use as a medicament. The CBD-type cannabinoid, cannabidiol-C1 (CBD-C1), is a naturally occurring cannabinoid that can be found in minor quantities in the cannabis plant. Furthermore, the 5 cannabinoid can be produced by synthetic means and a method for the production of CBD-C1 is described herein. In addition, disclosed herein are data which demonstrate the efficacy of CBD-C1 in models of disease.
Cajan element structure and methods in the application of preparing antibacterial drug
-
Paragraph 0042; 0046; 0047, (2018/02/04)
The invention belongs to the field of medicines and discloses a longistyline analogue and an application thereof in preparation of an antibacterial drug. The longistyline analogue has a structure as shown in the formula I described in the specification, w